Indeed, the BRAFV595E mutation which is present in 75–87% of canine UC tumors [28] has been shown to be associated with tumor-produced CCL17 and regulatory T cell infiltration in dogs with UC highlighting the potential influence of the tumor immune environment on UC tumor behavior. The gene discussed is CCL17; the disease is neoplasm.